Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2005;58:1046-1050; doi:10.1136/jcp.2004.024919
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma

F Farabegoli1, C Ceccarelli2, D Santini2 and M Taffurelli3

1 Department of Experimental Pathology, University of Bologna, Via San Giacomo, 14, 40126 Bologna, Italy
2 Institute of Anatomical and Pathological Histology, University of Bologna
3 Breast Cancer Surgical Unit, First Surgical Clinic, University of Bologna

Correspondence to:
Correspondence to:
Dr F Farabegoli
Department of Experimental Pathology, University of Bologna, Via San Giacomo, 14, 40126 Bologna, Italy; frbfl{at}alma.unibo.it

Aims: To investigate SOCS-2 (suppressor of cytokine signalling 2) protein expression in breast carcinoma samples in relation to biopathological parameters and survival.

Methods: A polyclonal antibody against SOCS-2 was used to study 50 archival breast carcinoma samples, collected from 1993 to 1995. The presence of SOCS-2 protein was investigated in relation to clinical and biological parameters used in breast cancer pathology. Fluorescence in situ hybridisation (FISH) was used to study whether SOCS-2 expression was related to SOCS-2 gene copy number.

Results: SOCS-2 protein was expressed in 34 of 50 breast carcinoma samples and was positively associated with low grade, low nuclear grade, and p27 protein. SOCS-2 expression was inversely related to Ki-67, cyclin A, retinoblastoma protein (pRb), and the epidermal growth factor receptor (EGFR). No relation with overall survival was demonstrated. SOCS-2 amplification was found in three samples. No relation between the number of FISH signals and SOCS-2 expression was found.

Conclusions: The significant correlation seen between SOCS-2 expression, grade, nuclear grade, p27, Ki-67, cyclin A, pRb, and EGFR labelling strongly supports the hypothesis that SOCS-2 loss might be related to cell proliferation and tumour growth in breast carcinoma. Gene copy number changes did not seem to play a role in SOCS-2 regulation and expression; other mechanisms might be involved and deserve further study.

Abbreviations: CIS, cytokine induced SRC homology 2 SH2 protein; EGFR, epidermal growth factor receptor; ER, oestrogen receptor; FISH, fluorescence in situ hybridisation; IHC, immunohistochemistry; %LIa, percentage of the labelled nuclear area over the total neoplastic nuclear area; OS, overall survival; PR, progesterone receptor; pRb, retinoblastoma protein; SOCS, suppressor of cytokine signalling

Keywords: breast carcinoma; fluorescence in situ hybridisation; suppressor of cytokine signalling 2; biopathological variables; prognosis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs